Research by Kappelmann et al. demonstrated that elevated systemic inflammation markers, including CRP and IL-6, are significantly associated with both depression and impaired glycemic control, highlighting the bidirectional relationship between metabolic dysfunction and mental health [126]. Here, IL6 is linked to depressive symptom measurement.